{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Orlando&page=17&state=Florida", "query": { "state": "Florida", "city": "Orlando", "page": 17 }, "page_size": 10 }, "pagination": { "page": 17, "page_size": 10, "total_count": 6846, "total_pages": 685, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Orlando&page=18&state=Florida&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Orlando&page=16&state=Florida&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T00:15:38.837Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00429091", "title": "A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Attention-Deficit/Hyperactivity Disorder", "ADHD" ], "interventions": [ { "name": "ABT-894", "type": "DRUG" }, { "name": "atomoxetine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 243, "start_date": "2007-01", "completion_date": null, "has_results": false, "last_update_posted_date": "2010-11-02", "last_synced_at": "2026-10-31T00:15:38.837Z", "location_count": 22, "location_summary": "San Francisco, California • Wildomar, California • Orlando, Florida + 19 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Wildomar", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Libertyville", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00429091" }, { "nct_id": "NCT01859390", "title": "Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "AquADEKs-2", "type": "DRUG" }, { "name": "control multivitamin", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": null, "sex": "ALL", "summary": "10 Years and older" }, "enrollment_count": 73, "start_date": "2013-06", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2017-07-14", "last_synced_at": "2026-10-31T00:15:38.837Z", "location_count": 15, "location_summary": "Tucson, Arizona • Aurora, Colorado • Orlando, Florida + 12 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Orlando", "state": "Florida" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01859390" }, { "nct_id": "NCT00389779", "title": "DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Darusentan", "type": "DRUG" }, { "name": "Guanfacine", "type": "DRUG" }, { "name": "Darusentan Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "35 Years to 80 Years" }, "enrollment_count": 849, "start_date": "2006-09", "completion_date": "2009-08", "has_results": false, "last_update_posted_date": "2014-03-18", "last_synced_at": "2026-10-31T00:15:38.837Z", "location_count": 87, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Montgomery, Alabama + 70 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00389779" }, { "nct_id": "NCT03491150", "title": "An Open-Label Crenezumab Study in Participants With Alzheimer's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "Crenezumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 149, "start_date": "2018-04-11", "completion_date": "2019-05-31", "has_results": true, "last_update_posted_date": "2020-07-13", "last_synced_at": "2026-10-31T00:15:38.837Z", "location_count": 32, "location_summary": "Newport Beach, California • Redlands, California • Sacramento, California + 28 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Redlands", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03491150" }, { "nct_id": "NCT02139124", "title": "The Efficacy and Safety of PRC-063 in Adult ADHD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "ADHD" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "PRC-063 25 mg", "type": "DRUG" }, { "name": "PRC-063 45 mg", "type": "DRUG" }, { "name": "PRC-063 70 mg", "type": "DRUG" }, { "name": "PRC-063 100 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rhodes Pharmaceuticals, L.P.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 375, "start_date": "2014-04", "completion_date": "2015-01", "has_results": true, "last_update_posted_date": "2019-05-07", "last_synced_at": "2026-10-31T00:15:38.837Z", "location_count": 33, "location_summary": "Los Angeles, California • National City, California • Newport Beach, California + 27 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Bradenton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02139124" }, { "nct_id": "NCT04886596", "title": "Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [ { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "RSVPreF3 OA vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 26675, "start_date": "2021-05-25", "completion_date": "2024-05-31", "has_results": true, "last_update_posted_date": "2025-07-31", "last_synced_at": "2026-10-31T00:15:38.837Z", "location_count": 60, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 54 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04886596" }, { "nct_id": "NCT06377488", "title": "Evaluation of the Clinical Performance of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Visual Acuity" ], "interventions": [ { "name": "JJVC Investigational Multifocal Toric Contact Lens manufactured in Senofilcon A (C3) material with UV blocker / HEV filter", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Johnson & Johnson Vision Care, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "40 Years to 70 Years" }, "enrollment_count": 176, "start_date": "2024-04-22", "completion_date": "2024-06-24", "has_results": true, "last_update_posted_date": "2025-10-28", "last_synced_at": "2026-10-31T00:15:38.837Z", "location_count": 15, "location_summary": "Jacksonville, Florida • Longwood, Florida • Maitland, Florida + 11 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Longwood", "state": "Florida" }, { "city": "Maitland", "state": "Florida" }, { "city": "Clinton", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06377488" }, { "nct_id": "NCT02493868", "title": "A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Depressive Disorder, Treatment-Resistant" ], "interventions": [ { "name": "Esketamine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Duloxetine (Oral Antidepressant)", "type": "DRUG" }, { "name": "Escitalopram (Oral antidepressant)", "type": "DRUG" }, { "name": "Sertraline (Oral Antidepressant)", "type": "DRUG" }, { "name": "Venlafaxine Extended Release (XR) (Oral Antidepressant)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 719, "start_date": "2015-10-01", "completion_date": "2018-02-16", "has_results": true, "last_update_posted_date": "2025-04-29", "last_synced_at": "2026-10-31T00:15:38.837Z", "location_count": 53, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Anaheim, California + 50 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02493868" }, { "nct_id": "NCT03691974", "title": "Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteoarthritis, Knee", "Osteoarthritis, Hip" ], "interventions": [ { "name": "Fasinumab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2018-10-15", "completion_date": "2021-01-07", "has_results": true, "last_update_posted_date": "2023-03-01", "last_synced_at": "2026-10-31T00:15:38.837Z", "location_count": 21, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Tucson, Arizona + 15 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03691974" }, { "nct_id": "NCT00718523", "title": "Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ovarian Neoplasms" ], "interventions": [ { "name": "AMG 479", "type": "DRUG" }, { "name": "AMG 479 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Translational Research in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 170, "start_date": "2009-01", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2016-01-12", "last_synced_at": "2026-10-31T00:15:38.837Z", "location_count": 23, "location_summary": "Alhambra, California • Burbank, California • Fullerton, California + 17 more", "locations": [ { "city": "Alhambra", "state": "California" }, { "city": "Burbank", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "La Verne", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00718523" } ] }